Press Release: GHIF Finances Registration of Moxidectin for Onchocerciasis
$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness If approved, moxidectin is expected to significantly accelerate the eradication of this terrible neglected disease March 8, 2015 (LONDON – UK): The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (Medicines Development) announced today a [...]